Our News on Newswise

Newswise: 6480f15c63237_ab92b93e-4534-42b0-8cc7-c9092ada6a94.jpeg

Study Shows Osimertinib Improves Survival Following Surgery for Non-Small Cell Lung Cancer

A new study led by Yale Cancer Center shows improved rates of survival and reduced risk of recurrence in patients with non-small cell lung cancer taking osimertinib (TAGRISSO), a targeted therapy, following surgery. Non-small cell lung cancer...
7-Jun-2023 5:20 PM EDT Add to Favorites

Newswise: 6475f947b83c3_Parkimage.jpeg

New findings reveal impact of changing environment for patients with cancer prescribed opioids

In response to the opioid epidemic in the United States, interventions to prevent over-prescribing and misuse of opioids were enacted at institutional, state, and federal levels. To assess how changes in the prescribing landscape affected patients,...
31-May-2023 7:05 AM EDT Add to Favorites

Newswise: 6466550f7198d_ASCO2023Image.jpeg

Yale Cancer Center and Smilow Cancer Hospital Physicians and Scientists Presenting Latest Advances at 2023 ASCO Annual Meeting

Yale Cancer Center and Smilow Cancer Hospital scientists and clinicians will present new research at the 2023 Annual Meeting of the American Society of Clinical Oncology (ASCO), June 2nd to June 6th at McCormick Place in Chicago, Illinois. This...
18-May-2023 12:50 PM EDT Add to Favorites

Newswise: 6462462b3f9b4_MyPACVisualAbstract7481.jpg

New Yale-led study identifies bereaved parents’ medical priorities for children with advanced cancer

For families facing the end of life of a loved one with pediatric cancer, robust quality measures to benchmark what parents value most in their child’s medical care do not currently exist. A new study helps identify what parents prioritize for...
16-May-2023 8:05 AM EDT Add to Favorites

Newswise: 6452820f4b6ee_KropManuscriptImageLancet.jpeg

New Study Shows Trastuzumab Deruxtecan Improves Survival for Patients with HER2-positive Metastatic Breast Cancer

A new phase III study has demonstrated the efficacy of trastuzumab deruxtecan (Enhertu) in patients with HER2-positive metastatic breast cancer whose cancers were resistant to previous treatment with trastuzumab emtansine. Both trastuzumab...
3-May-2023 12:00 PM EDT Add to Favorites

Newswise: 64511e5d86f89_ONSCongress.jpeg

Smilow Cancer Hospital Nurses Present New Research at the Annual ONS Congress

This week, 18 Smilow Cancer Hospital nurses will present new oncologic research at the 48th Annual Congress of the Oncology Nursing Society in San Antonio, Texas. Their findings will be revealed during poster and oral presentation sessions from...
2-May-2023 10:40 AM EDT Add to Favorites

Connecticut Magazine’s 2023 “Top Doctors” issue recognizes 81 Smilow Cancer Hospital and Yale Cancer Center physicians

The complete “Top Doctors” list appears in the May 2023 issue of Connecticut Magazine. Congratulations to this year’s “Top Doctors” affiliated with Smilow Cancer Hospital and Yale Cancer Center.
1-May-2023 10:00 AM EDT Add to Favorites

See All News

Our Experts on Newswise

Newswise: 6455016aea4f1_KiranTuraga.jpeg

HIPEC Surgery Brings Advanced Abdominal Cancer Treatment to Smilow Cancer Hospital

A technique that delivers high doses of heated chemotherapy directly to the abdominal cavity is a promising treatment for certain patients with Stage IV cancer. Hyperthermic intraperitoneal chemotherapy (HIPEC) kills cancer cells in the abdomen...
5-May-2023 9:30 AM EDT

Newswise: 61bfb61a93df6_Kevin Billingsley MD bigger 2.jpg

How Patients with Cancer Can Navigate COVID-19 for the Holidays

Smilow Cancer Hospital expert has the latest recommendations for patients and families.
20-Dec-2021 8:00 AM EST

Newswise: MichaelGirardiMDPhD.jpg

Five Ways to Lower Your Skin Cancer Risk

Experts at Yale Cancer Center say unless you take the right precautions, sun exposure (even if you don't get scorched) can damage your skin, causing wrinkles, age spots and even skin cancer.
22-Jun-2018 10:05 AM EDT

Yale Expert Discusses Treatment for Endometrial Cancer

Dr. Alesandro Santin Discusses Treatment for Endometrial Cancer
3-Apr-2018 3:55 PM EDT

See All Experts

Our YouTube Videos


Yale Cancer Center combines a tradition of innovative cancer treatment and quality care for our patients. A National Cancer Institute (NCI) designated comprehensive cancer center for over 45 years, Yale Cancer Center is one of only 54 Centers in the nation.

Yale Cancer Center is a collaboration between nationally and internationally renowned scientists and physicians at Yale School of Medicine and Smilow Cancer Hospital. This partnership enables the Center to provide the best approaches for prevention, detection, diagnosis, and treatment for cancer.



Mike Masciadrelli
Media Relations Officer



Renee Gaudette
Director of Marketing & Public Affairs



Emily Montemerlo
Marketing Coordinator





Instagram feed not yet configured. Click "Edit Instagram Feed" to enter your Instagram details.